{"id":5238,"date":"2019-01-17T15:38:03","date_gmt":"2019-01-17T17:38:03","guid":{"rendered":"https:\/\/mapesolutions.com\/?p=5238"},"modified":"2021-10-26T14:06:19","modified_gmt":"2021-10-26T17:06:19","slug":"immunobiological-case-structuring-an-access-strategy-through-focus-group","status":"publish","type":"post","link":"https:\/\/mapesolutions.com\/en\/immunobiological-case-structuring-an-access-strategy-through-focus-group\/","title":{"rendered":"Immunobiologicals Case &#8211; Structuring an access strategy through Focus Group"},"content":{"rendered":"<p>[:pb]<\/p>\n<p style=\"font-weight: 400;\">One of the biggest sources of innovation in the pharmaceutical industry today is biological medicines. The high complexity that they have demands more specialization in all the processes of elaboration of this technology.<\/p>\n<p style=\"font-weight: 400;\">In this context, a pharmaceutical laboratory had the challenge of mapping the segment in Brazil in order to promote the incorporation of technology as accurately as possible. Find out how the Focus Group solution adopted by MAPES enabled a strategic result, with distinct and relevant points of view for all involved stakeholders.<\/p>\n<p style=\"font-weight: 400;\">To learn more about our solutions for incorporating healthcare technologies, download the MAPES e-book:  <a href=\"https:\/\/conteudo.mapesolutions.com\/case-imunobiologicos-estruturando-uma-estrategia\">HERE<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>[:pb] One of the biggest sources of innovation in the pharmaceutical industry today is biological medicines. The high complexity that they have demands more specialization in all the processes of elaboration of this technology. In this context, a pharmaceutical laboratory had the challenge of mapping the segment in Brazil in order to promote the incorporation [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-5238","post","type-post","status-publish","format-standard","hentry","category-sem-categoria"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>[:pb]Immunobiologicals Case - Structuring an access strategy through Focus Group[:]<\/title>\n<meta name=\"description\" content=\"{:pb}Uma das maiores fontes de inova\u00e7\u00e3o na ind\u00fastria farmac\u00eautica atualmente s\u00e3o os medicamentos biol\u00f3gicos. {:}\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/mapesolutions.com\/en\/immunobiological-case-structuring-an-access-strategy-through-focus-group\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"[:pb]Immunobiologicals Case - Structuring an access strategy through Focus Group[:]\" \/>\n<meta property=\"og:description\" content=\"{:pb}Uma das maiores fontes de inova\u00e7\u00e3o na ind\u00fastria farmac\u00eautica atualmente s\u00e3o os medicamentos biol\u00f3gicos. {:}\" \/>\n<meta property=\"og:url\" content=\"https:\/\/mapesolutions.com\/en\/immunobiological-case-structuring-an-access-strategy-through-focus-group\/\" \/>\n<meta property=\"og:site_name\" content=\"Mapes\" \/>\n<meta property=\"article:published_time\" content=\"2019-01-17T17:38:03+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-10-26T17:06:19+00:00\" \/>\n<meta name=\"author\" content=\"Dev Mapes\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dev Mapes\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/mapesolutions.com\\\/en\\\/immunobiological-case-structuring-an-access-strategy-through-focus-group\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/mapesolutions.com\\\/en\\\/immunobiological-case-structuring-an-access-strategy-through-focus-group\\\/\"},\"author\":{\"name\":\"Dev Mapes\",\"@id\":\"https:\\\/\\\/mapesolutions.com\\\/en\\\/#\\\/schema\\\/person\\\/febe1d3b0d68ad13b8a322cb90c28b07\"},\"headline\":\"Immunobiologicals Case &#8211; Structuring an access strategy through Focus Group\",\"datePublished\":\"2019-01-17T17:38:03+00:00\",\"dateModified\":\"2021-10-26T17:06:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/mapesolutions.com\\\/en\\\/immunobiological-case-structuring-an-access-strategy-through-focus-group\\\/\"},\"wordCount\":111,\"commentCount\":0,\"articleSection\":[\"Sem categoria\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/mapesolutions.com\\\/en\\\/immunobiological-case-structuring-an-access-strategy-through-focus-group\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/mapesolutions.com\\\/en\\\/immunobiological-case-structuring-an-access-strategy-through-focus-group\\\/\",\"url\":\"https:\\\/\\\/mapesolutions.com\\\/en\\\/immunobiological-case-structuring-an-access-strategy-through-focus-group\\\/\",\"name\":\"[:pb]Immunobiologicals Case - Structuring an access strategy through Focus Group[:]\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/mapesolutions.com\\\/en\\\/#website\"},\"datePublished\":\"2019-01-17T17:38:03+00:00\",\"dateModified\":\"2021-10-26T17:06:19+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/mapesolutions.com\\\/en\\\/#\\\/schema\\\/person\\\/febe1d3b0d68ad13b8a322cb90c28b07\"},\"description\":\"{:pb}Uma das maiores fontes de inova\u00e7\u00e3o na ind\u00fastria farmac\u00eautica atualmente s\u00e3o os medicamentos biol\u00f3gicos. {:}\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/mapesolutions.com\\\/en\\\/immunobiological-case-structuring-an-access-strategy-through-focus-group\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/mapesolutions.com\\\/en\\\/immunobiological-case-structuring-an-access-strategy-through-focus-group\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/mapesolutions.com\\\/en\\\/immunobiological-case-structuring-an-access-strategy-through-focus-group\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/mapesolutions.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Immunobiologicals Case &#8211; Structuring an access strategy through Focus Group\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/mapesolutions.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/mapesolutions.com\\\/en\\\/\",\"name\":\"Mapes\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/mapesolutions.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/mapesolutions.com\\\/en\\\/#\\\/schema\\\/person\\\/febe1d3b0d68ad13b8a322cb90c28b07\",\"name\":\"Dev Mapes\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/50a7b616ce3fcf41aaaba30ac5823a5ac2216c39b68c1e7bd67a355f8db55c48?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/50a7b616ce3fcf41aaaba30ac5823a5ac2216c39b68c1e7bd67a355f8db55c48?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/50a7b616ce3fcf41aaaba30ac5823a5ac2216c39b68c1e7bd67a355f8db55c48?s=96&d=mm&r=g\",\"caption\":\"Dev Mapes\"},\"url\":\"https:\\\/\\\/mapesolutions.com\\\/en\\\/author\\\/dev-mapes\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"[:pb]Immunobiologicals Case - Structuring an access strategy through Focus Group[:]","description":"{:pb}Uma das maiores fontes de inova\u00e7\u00e3o na ind\u00fastria farmac\u00eautica atualmente s\u00e3o os medicamentos biol\u00f3gicos. {:}","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/mapesolutions.com\/en\/immunobiological-case-structuring-an-access-strategy-through-focus-group\/","og_locale":"en_US","og_type":"article","og_title":"[:pb]Immunobiologicals Case - Structuring an access strategy through Focus Group[:]","og_description":"{:pb}Uma das maiores fontes de inova\u00e7\u00e3o na ind\u00fastria farmac\u00eautica atualmente s\u00e3o os medicamentos biol\u00f3gicos. {:}","og_url":"https:\/\/mapesolutions.com\/en\/immunobiological-case-structuring-an-access-strategy-through-focus-group\/","og_site_name":"Mapes","article_published_time":"2019-01-17T17:38:03+00:00","article_modified_time":"2021-10-26T17:06:19+00:00","author":"Dev Mapes","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Dev Mapes","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/mapesolutions.com\/en\/immunobiological-case-structuring-an-access-strategy-through-focus-group\/#article","isPartOf":{"@id":"https:\/\/mapesolutions.com\/en\/immunobiological-case-structuring-an-access-strategy-through-focus-group\/"},"author":{"name":"Dev Mapes","@id":"https:\/\/mapesolutions.com\/en\/#\/schema\/person\/febe1d3b0d68ad13b8a322cb90c28b07"},"headline":"Immunobiologicals Case &#8211; Structuring an access strategy through Focus Group","datePublished":"2019-01-17T17:38:03+00:00","dateModified":"2021-10-26T17:06:19+00:00","mainEntityOfPage":{"@id":"https:\/\/mapesolutions.com\/en\/immunobiological-case-structuring-an-access-strategy-through-focus-group\/"},"wordCount":111,"commentCount":0,"articleSection":["Sem categoria"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/mapesolutions.com\/en\/immunobiological-case-structuring-an-access-strategy-through-focus-group\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/mapesolutions.com\/en\/immunobiological-case-structuring-an-access-strategy-through-focus-group\/","url":"https:\/\/mapesolutions.com\/en\/immunobiological-case-structuring-an-access-strategy-through-focus-group\/","name":"[:pb]Immunobiologicals Case - Structuring an access strategy through Focus Group[:]","isPartOf":{"@id":"https:\/\/mapesolutions.com\/en\/#website"},"datePublished":"2019-01-17T17:38:03+00:00","dateModified":"2021-10-26T17:06:19+00:00","author":{"@id":"https:\/\/mapesolutions.com\/en\/#\/schema\/person\/febe1d3b0d68ad13b8a322cb90c28b07"},"description":"{:pb}Uma das maiores fontes de inova\u00e7\u00e3o na ind\u00fastria farmac\u00eautica atualmente s\u00e3o os medicamentos biol\u00f3gicos. {:}","breadcrumb":{"@id":"https:\/\/mapesolutions.com\/en\/immunobiological-case-structuring-an-access-strategy-through-focus-group\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/mapesolutions.com\/en\/immunobiological-case-structuring-an-access-strategy-through-focus-group\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/mapesolutions.com\/en\/immunobiological-case-structuring-an-access-strategy-through-focus-group\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/mapesolutions.com\/en\/"},{"@type":"ListItem","position":2,"name":"Immunobiologicals Case &#8211; Structuring an access strategy through Focus Group"}]},{"@type":"WebSite","@id":"https:\/\/mapesolutions.com\/en\/#website","url":"https:\/\/mapesolutions.com\/en\/","name":"Mapes","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mapesolutions.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/mapesolutions.com\/en\/#\/schema\/person\/febe1d3b0d68ad13b8a322cb90c28b07","name":"Dev Mapes","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/50a7b616ce3fcf41aaaba30ac5823a5ac2216c39b68c1e7bd67a355f8db55c48?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/50a7b616ce3fcf41aaaba30ac5823a5ac2216c39b68c1e7bd67a355f8db55c48?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/50a7b616ce3fcf41aaaba30ac5823a5ac2216c39b68c1e7bd67a355f8db55c48?s=96&d=mm&r=g","caption":"Dev Mapes"},"url":"https:\/\/mapesolutions.com\/en\/author\/dev-mapes\/"}]}},"_links":{"self":[{"href":"https:\/\/mapesolutions.com\/en\/wp-json\/wp\/v2\/posts\/5238","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mapesolutions.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mapesolutions.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mapesolutions.com\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/mapesolutions.com\/en\/wp-json\/wp\/v2\/comments?post=5238"}],"version-history":[{"count":4,"href":"https:\/\/mapesolutions.com\/en\/wp-json\/wp\/v2\/posts\/5238\/revisions"}],"predecessor-version":[{"id":6563,"href":"https:\/\/mapesolutions.com\/en\/wp-json\/wp\/v2\/posts\/5238\/revisions\/6563"}],"wp:attachment":[{"href":"https:\/\/mapesolutions.com\/en\/wp-json\/wp\/v2\/media?parent=5238"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mapesolutions.com\/en\/wp-json\/wp\/v2\/categories?post=5238"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mapesolutions.com\/en\/wp-json\/wp\/v2\/tags?post=5238"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}